Corient Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 25,218 shares of GILD stock, worth $2.22 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

25,218

Previous 23,513 7.25%

Holding current value

$2.22 Million

Previous $1.45 Million 7.22%

% of portfolio

0.12%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $101,515 - $115,957	1,705 Added 7.25%	25,218 $1.56 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $283,809 - $319,654	4,917 Added 26.44%	23,513 $1.45 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $58,093 - $72,797	-1,003 Reduced 5.12%	18,596 $1.11 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $30,169 - $34,242	465 Added 2.43%	19,599 $1.42 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $8,732 - $9,420	129 Added 0.68%	19,134 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $111,770 - $122,125	1,761 Added 10.21%	19,005 $1.31 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $351,900 - $401,517	5,865 Added 51.54%	17,244 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $230,225 - $262,331	-4,064 Reduced 26.32%	11,379 $663,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $305,594 - $384,231	-4,921 Reduced 24.17%	15,443 $976,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $424,563 - $492,996	5,869 Added 40.49%	20,364 $1.57 Million
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $196,157 - $251,249	3,132 Added 27.56%	14,495 $1.08 Million
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $51,699 - $56,867	839 Added 7.97%	11,363 $739,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $25,316 - $27,945	-405 Reduced 3.71%	10,524 $667,000
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $227,867 - $255,526	3,683 Added 50.83%	10,929 $738,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $1.42 Million - $1.59 Million	-22,726 Reduced 75.82%	7,246 $471,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $729,749 - $952,266	-12,054 Reduced 28.68%	29,972 $1.88 Million
Q2 2018 Oct 02, 2018	BUY	$64.88 - $75.68 $381,299 - $444,771	5,877 Added 16.26%	42,026 $2.98 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $1.22 Million - $1.48 Million	16,708 Added 85.94%	36,149 $2.73 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $1.03 Million - $1.2 Million	-14,421 Reduced 42.59%	19,441 $1.39 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $725,715 - $860,170	-10,064 Reduced 22.91%	33,862 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-645 Reduced 1.45%	43,926 $3.11 Million
Q1 2017 Aug 17, 2017	SELL	N/A	-16,142 Reduced 26.59%	44,571 $3.03 Million
Q1 2017 Aug 14, 2017	BUY	N/A	60,713	60,713 $2.54 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Gilead Sciences, Inc. Transaction History